|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McIntyre A and Ganti AK: Lung cancer-A
global perspective. J Surg Oncol. 115:550–554. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
I H and Cho JY: Lung cancer biomarkers.
Adv Clin Chem. 72:107–170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vargas AJ and Harris CC: Biomarker
development in the precision medicine era: Lung cancer as a case
study. Nat Rev Cancer. 16:525–537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baylin SB and Jones PA: A decade of
exploring the cancer epigenome-biological and translational
implications. Nat Rev Cancer. 11:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liloglou T, Bediaga NG, Brown BR, Field JK
and Davies MP: Epigenetic biomarkers in lung cancer. Cancer Lett.
342:200–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Walter K, Holcomb T, Januario T, Yauch RL,
Du P, Bourgon R, Seshagiri S, Amler LC, Hampton GM and S Shames D:
Discovery and development of DNA methylation-based biomarkers for
lung cancer. Epigenomics. 6:59–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou J, Wang H, Lu A, Hu G, Luo A, Ding F,
Zhang J, Wang X, Wu M and Liu Z: A novel gene, NMES1, downregulated
in human esophageal squamous cell carcinoma. Int J Cancer.
101:311–316. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arai M, Imazeki F, Sakai Y, Mikata R, Tada
M, Seki N, Shimada H, Ochiai T and Yokosuka O: Analysis of the
methylation status of genes up-regulated by the demethylating
agent, 5-aza-2′-deoxycytidine, in esophageal squamous cell
carcinoma. Oncol Rep. 20:405–412. 2008.PubMed/NCBI
|
|
10
|
Sova P, Feng Q, Geiss G, Wood T, Strauss
R, Rudolf V, Lieber A and Kiviat N: Discovery of novel methylation
biomarkers in cervical carcinoma by global demethylation and
microarray analysis. Cancer Epidemiol Biomarkers Prev. 15:114–123.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Spisák S, Kalmár A, Galamb O, Wichmann B,
Sipos F, Péterfia B, Csabai I, Kovalszky I, Semsey S, Tulassay Z
and Molnár B: Genome-wide screening of genes regulated by DNA
methylation in colon cancer development. PLoS One. 7:e462152012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Riggs PK, Angel JM, Abel EL and Digiovanni
J: Differential gene expression in epidermis of mice sensitive and
resistant to phorbol ester skin tumor promotion. Mol Carcinog.
44:122–136. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Detterbeck FC, Boffa DJ and Tanoue LT: The
new lung cancer staging system. Chest. 136:260–271. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shaw RJ, Hall GL, Lowe D, Bowers NL,
Liloglou T, Field JK, Woolgar JA and Risk JM: CpG island
methylation phenotype (CIMP) in oral cancer: Associated with a
marked inflammatory response and less aggressive tumour biology.
Oral Oncol. 43:878–886. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee SM, Lee WK, Kim DS and Park JY:
Quantitative promoter hypermethylation analysis of RASSF1A in lung
cancer: Comparison with methylation-specific PCR technique and
clinical significance. Mol Med Rep. 5:239–244. 2012.PubMed/NCBI
|
|
16
|
Deaton AM and Bird A: CpG islands and the
regulation of transcription. Genes Dev. 25:1010–1022. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Selamat SA, Chung BS, Girard L, Zhang W,
Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al:
Genome-scale analysis of DNA methylation in lung adenocarcinoma and
integration with mRNA expression. Genome Res. 22:1197–1211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bert SA, Robinson MD, Strbenac D, Statham
AL, Song JZ, Hulf T, Sutherland RL, Coolen MW, Stirzaker C and
Clark SJ: Regional activation of the cancer genome by long-range
epigenetic remodeling. Cancer Cell. 23:9–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Irizarry RA, Ladd-Acosta C, Wen B, Wu Z,
Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al:
The human colon cancer methylome shows similar hypo- and
hypermethylation at conserved tissue-specific CpG island shores.
Nat Genet. 41:178–186. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim DS, Lee SM, Yoon GS, Choi JE and Park
JY: Infrequent hypermethylation of the PTEN gene in Korean
non-small cell lung cancers. Cancer Sci. 101:568–572. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lessi F, Beggs A, de Palo M, Anti M,
Macarone Palmieri R, Francesconi S, Gomes V, Bevilacqua G,
Tomlinson I and Segditsas S: Down-regulation of
serum/glucocorticoid regulated kinase 1 in colorectal tumours is
largely independent of promoter hypermethylation. PLoS One.
5:e138402010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Braga LC, Silva LM, Ramos AP, Piedade JB,
Vidigal PV, Traiman P and da Silva Filho AL: Single CpG island
methylation is not sufficient to maintain the silenced expression
of CASPASE-8 apoptosis-related gene among women with epithelial
ovarian cancer. Biomed Pharmacother. 68:87–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Floyd BJ, Wilkerson EM, Veling MT, Minogue
CE, Xia C, Beebe ET, Wrobel RL, Cho H, Kremer LS, Alston CL, et al:
Mitochondrial protein interaction mapping identifies regulators of
respiratory chain function. Mol Cell. 63:621–632. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Garcia-Heredia JM and Carnero A: Decoding
Warburg's hypothesis: Tumor-related mutations in the mitochondrial
respiratory chain. Oncotarget. 6:41582–41599. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maunakea AK, Chepelev I, Cui K and Zhao K:
Intragenic DNA methylation modulates alternative splicing by
recruiting MeCP2 to promote exon recognition. Cell Res.
23:1256–1269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hitchins MP, Rapkins RW, Kwok CT,
Srivastava S, Wong JJ, Khachigian LM, Polly P, Goldblatt J and Ward
RL: Dominantly inherited constitutional epigenetic silencing of
MLH1 in a cancer-affected family is linked to a single nucleotide
variant within the 5′UTR. Cancer Cell. 20:200–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Forn M, Muñoz M, Tauriello DV,
Merlos-Suárez A, Rodilla V, Bigas A, Batlle E, Jordà M and Peinado
MA: Long range epigenetic silencing is a trans-species mechanism
that results in cancer specific deregulation by overriding the
chromatin domains of normal cells. Mol Oncol. 7:1129–1141. 2013.
View Article : Google Scholar : PubMed/NCBI
|
